AesRx, LLC — Form D/A
AesRx, LLC of NEWTON, MA, a company, filed a Form D amendment with the SEC on 2011-06-30. The offering totals $3.5M, of which $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-06-30
- Form: D/A
- Accession: 0001521095-11-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $3.5M
- Amount sold: $1.5M
- Remaining: $2.0M
- Minimum investment: $15K
- Investors: 8
- Date of first sale: 2011-05-06
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-160124
Issuer
- Name: AesRx, LLC
- CIK: 0001521095
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 275 GROVE STREET, NEWTON, MA, 02466
- Phone: 617-965-2521
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Maggie Flanagan LeFlore | Director | Newton, MA |
| Mary K Pendergast | Director | Newton, MA |
| Stephen R Seiler | Director | Newton, MA |
| Stephen R Seiler | Executive Officer | Newton, MA |
| Maggie R LeFlore | Director | Newton, MA |
| R. John K Fletcher | Director | Newton, MA |
| Colin R Hill | Director | Newton, MA |
| Colin R. Hill | Director | Newton, MA |
| Stephen R. Seiler | Director | Newton, MA |
| Stephen R. Seiler | Executive Officer | Newton, MA |
| Maggie R. LeFlore | Director | Newton, MA |
| Mary K. Pendergast | Director | Newton, MA |
Other filings by this issuer (7)
More